Common sense investment opportunities around the world

Weekly newsletter (free)

In-depth research reports (from USD 49 p.a.)

Expand your thinking by tapping Into my 25+ years of global investment research expertise


Discover world-class companies trading at low prices


Beat low interest rates with dividend yield strategies


Benefit from a different, independent view of the world

Latest Reports for Members

Novavax: The

Novavax: The vax company that came from nowhere

30 July 2021

I recently wondered which coronavirus vaccine I would pick for myself - if or when I get vaccinated.

When I asked a trusted medical doctor for his advice about coronavirus vaccinations, he mentioned an option that I hadn't thought of yet: "If you aren't in a risk group and can wait, then wait for Novavax to hit the market in autumn 2021."

"Novavax" is both a vaccine and a company. The broader public isn't aware of it yet, but there are some metrics about the company that should make you pay attention:

  • Novavax received USD 2bn in public support to launch its vaccine, more than any other American vaccine company.
  • Countries around the world have already ordered 1.4 BILLION Novavax doses, which earlier this year made it the second-most ordered vaccine on record.
  • Those countries with pending pre-orders aren't just developing nations but include the US (110m doses), the UK (60m), and Australia (51m).

Science Magazine asked whether Novavax is going to produce the "best" coronavirus vaccine.

Would you have known about these details? If not, it's probably worth your time to read on.

"Dollar stores" are coming to Europe

IWG cover

IWG plc: the hybrid work model stock

The next Argentinean crisis investing opportunity

The next Argentinean crisis investing opportunity

Apollo Global Management cover

Apollo Global: the next Berkshire Hathaway?

Free weekly dispatches

Join for free to get my weekly columns with investment insights from around the world - and my FREE eBook "The world's best investing blogs"

Discover my investment ideas

Curious how my in-depth research reports look like? Download a FREE sample report (PDF - 6MB)


What members say


Your reports are always a joy to read and they give a solid perspective on interesting investment opportunities. Big thanks for that.

Tibor, Oman


This Membership is the best investment in your own stock market future. Anyone looking for an experienced opportunity finder will find what they need with Swen Lorenz!

Moritz H., Germany


Unrivaled value for retail investors in your reports. Gazprom actually helped me pay off one of my student loans which I've been struggling with for a while. Your work is changing lives.

Tyler, USA


Thanks again for all your great reports and I do already look forward to the next one!

Johannes, Hong Kong


Have read through all your reports and just want to thank you again for the amazing insight. Can't tell you how valuable and interesting I find them, just what I am looking for.

Steve P., Australia


You are the Sherlock Holmes of the stock market. Love your analysis. It's not only pretty accurate but fun to read.

Pablo, Argentina

As seen in

Most recent

Latest reports (for Members only)

Novavax: The "best" coronavirus vaccine and an undervalued stock?

Novavax: The "best" coronavirus vaccine and an undervalued stock?

Can coronavirus vaccine maker Novavax profit from the vast majority of unvaccinated people, and make vaccine sceptics fall in love with it?

"Dollar stores" are coming to Europe cover

"Dollar stores" are coming to Europe

This company is one of the few publicly-listed European companies that lets you benefit from the deep-discount retail trend.

IWG cover

IWG plc: THE hybrid work model stock

Flexible office space provider IWG is gearing up for a large, tax-free capital return which could give shareholders all their money back while staying invested.